ADRC Affiliated Researchers

Amy Abramowitz, M.D.

Geriatric Psychiatrist

UNC-Chapel Hill
Alzheimer’s Disease
Dementia Care
Geriatric psychiatrist specializing in taking care of older adults with mental health and neurocognitive disorders.

Leah Acker M.D, Ph.D.

Assistant Professor in Anesthesiology

Duke University
Cognition
Neurodegeneration
Neuropharmacology

Allison Aiello, Ph.D.

Professor and Social Epidemiology Program Leader

UNC-Chapel Hill
Epidemiology & Population Health
Research interests include: prevention of infectious diseases in the community setting; life course, infection, and chronic disease; genomics, aging, and immunity.

Adrienne Aiken Morgan, Ph.D.

UNC-Chapel Hill
My professional and research interests lie at the intersection of four broad areas of inquiry: sociocultural experience (e.g., race & ethnicity, education), cognition, aging, and health.

Igor Akushevich, Ph.D.

Research Professor

Duke University
Alzheimer’s Disease
Epidemiology & Population Health

Alison Axtman, Ph.D.

Assistant Professor

UNC-Chapel Hill
Alzheimer’s Disease
Cell Biology – Immunology
Cell Biology – Neurodegeneration
Cellular Pathology
Dr. Axtman’s research focuses on the synthesis of small molecules that selectively modulate proteins implicated in disease-propagating pathways. She works at the interface of chemistry and biology. She is funded to develop reagents to validate novel therapeutic hypotheses related to AD.

Alexandra Badea Ph.D.

Associate Professor

Duke University
Alzheimer’s Disease
Biomarkers
Neuroimaging
Current Research interests: Alzheimer’s Disease, Brain Imaging, MRI, Connectivity, Multivariate Biomarkers, Image Analysis, Neurological Conditions.

Cristian Badea, Ph.D.

Duke University
Biomarkers
Spectral CT, Cardiac CT, Image Reconstruction, Deep Learning, Nanoparticles, Theranostics, Co-Clinical cancer trials, Small Animal Imaging

Ben A. Bahr, Ph.D.

Distinguished Professor of Molecular Biology & Biochemistry

UNC Pembroke
Alzheimer’s Disease
Cell Biology – Neurodegeneration
Neurodegeneration
Bahr’s team focuses on synaptic vulnerability that contributes to AD risk factors, to improve understanding of the synaptopathy initiated by seizure- and stroke-type excitotoxicity, TBI, and blast exposures – all suspected of elevating the risk of dementia later in life.

Luke Bartelt

Graduate Student

Duke University
Animal Models
Cell Biology – Neurodegeneration
Neurodegeneration
Interested in understanding molecular mechanisms of Neurodegeneration through genetic mouse models and single-cell genomic technologies. Working to identify cell-type specific gene regulatory pathways driving neurodegeneration for next-generation gene therapy approaches.

Rashmita Basu, PhD

Assistant Professor

East Carolina University
Epidemiology & Population Health
REC Scholar Project: Improving Health and Well-being of People with Alzheimer’s Disease and Related Dementias and their Family Caregivers in Eastern North Carolina

John Batsis, M.D.

Associate Professor

UNC-Chapel Hill
Clinical Aging Research
Clinical Trials
Dementia Care
Epidemiology & Population Health
Clinical: Geriatric Medicine, Obesity, Health Promotion, Frailty Research: Obesity and Physical Function in Older Adults; Using technology (telemedicine, remote monitoring) to enhance health in older adults

Keisha Leanne Bentley-Edwards, M.A., Ph.D.

Associate Professor

Duke University
Care Givers & Community Support
Epidemiology & Population Health
My work specifically examines how race, culture and racism stress influence how the world responds to Black Americans and how this influences health and social disparities. I develop culturally cognizant measures, specifically in the areas of racial/ethnic socialization, racial cohesion and dissonance and same-race violence. As an interdisciplinary researcher, I examine the racial and societal contexts that influence health, coping and well-being in schools, communities and within families.

Miles Berger, MD, PhD

Associate Core Leader

Duke University
Alzheimer’s Disease
Bioinformatics
Clinical Trials
Cognition
Neurodegeneration
Neuroimaging
Neuroinflammation
Neuropharmacology
Research interests include: Delirium, Postoperative Neurocognitive Disorders, APOE4 biology, Multi-omic studies

Nrupen Bhavsar, Ph.D.

Associate Professor

Duke University
Bioinformatics
Epidemiology & Population Health
My primary research interests are in the use of novel sources of data, including the EHR, to conduct chronic disease research at the intersection of informatics, biostatistics, and epidemiology. My ongoing work aims to integrate informatics, epidemiology, and biostatistics to reduce the burden of chronic disease.

Charlotte Boettiger, Ph.D.

Professor

UNC-Chapel Hill
Biomarkers
Genetics
Work focuses on improving our understanding of the neurobiology of substance use disorders (SUDs) by identifying and characterizing neurocognitive biomarkers and intermediate phenotypes.

Andrea Bozoki, MD

Core Leader

UNC-Chapel Hill
Alzheimer’s Disease
Clinical Trials
Neurodegeneration

Jan Busby-Whitehead, MD

Core Leader

UNC-Chapel Hill
Alzheimer’s Disease
Dementia Care
Genetics
Dr. Busby-Whitehead is the M. Andrew Greganti Distinguished Professor of Medicine, Chief of the Division of Geriatrics, and Director of the Center for Aging and Health at the UNC School of Medicine. She is also the Co-Lead for the ADRC Research Education Component (REC) Core. She is committed to the preservation and improvement of patient health through research and to funded programs that serve to develop and increase the reach of geriatric education and training of physicians and healthcare professionals in the field of aging.

John Buse, M.D, Ph.D.

Professor

UNC-Chapel Hill
Alzheimer’s Disease
Behavioral Pathology
Clinical Trials
Cognition
The UNC Endocrinology Diabetes Obesity Clinical Research Unit (ENDO CRU) is a leading site for clinical and translational studies of diabetes, obesity and its complications. We are well positioned to help apply diabetes treatments to cognitive disorders and recruit patients with diabetes and obesity to AD translational studies.

Jamie Capal, M.D.

UNC-Chapel Hill
Biomarkers
Clinical Trials
Genetics
Research interests include studying neurodevelopmental disorders across the lifespan, including Down syndrome, Fragile X syndrome, Angelman syndrome, and Tuberous Sclerosis Complex, and the relationship between early neurodevelopmental conditions and later neurodegeneration.